This page is maintained and edited by Hellen Popovich (Senior Editor at World Wide News Flash since May, 2009).
You can contribute to this page by sending an email to [email protected] or by using our contact form below.

Avastin

July 21, 2010 The FDA Finds Avastin Does Not Shrink Tumors Or Help Patients Live ... Posted by Hellen Popovich The Food and Drug Administration approved Roche's blockbuster Avastin in 2008 based on early-stage trials showing it shrank tumors caused by breast cancer. The decision was controversial because drugs for cancer patients who have never [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 21, 2010 Avastin Approved In 2008 Based Send by Zeeshan Avastin was approved in 2008, based on the test results show that helped reduce breast tumors, indicating that the drug can help breast cancer. However, [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 NHS Regulator Rejects Breast Cancer Drug Bevacizumab (Avastin) Posted by Hellen Popovich NICE rejects bevacizumab (Avastin) for use in combination with a taxane due to uncertain evidence base but final guidance not yet given. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 21, 2010 Avastin Not Good For Breast Cancer?! | Researcher's Note Send by Administrator A Food and Drug Administration advisory committee Tuesday recommended that the agency withdraw approval of Avastin for treating breast cancer. However, thi [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Gemzar Plus Avastin Does Not Improve Survival In Advanced ... Send by CancerConnect Results from a recent Phase III trial indicate that the addition of the targeted therapy Avastin (bevacizumab) to the chemotherapy drug Gemzar (gemcitabine) does not improve survival in advanced pancreatic cancer. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 FDA Panel: Data Did Not Show Benefits With Avastin ... Posted by Hellen Popovich Federal health advisers say unanimously that a follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 21, 2010 Avastin Largely Safe For Patients With Type Of Advanced Lung ... Send by cosmepic TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced. [...] Rating: 1 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Study: Avastin Didn't Extend Life Of Breast Cancer Patients Posted by Hellen Popovich US government health scientists said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication. [...] Rating: 3 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Bevacizumab - Wikipedia, The Free Encyclopedia Posted by Hellen Popovich Bevacizumab (trade name Avastin, Genentech / Roche) is a humanized monoclonal antibody that recognizes and blocks vascular endothelial growth factor A (VEGF-A). [1] [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 21, 2010 Health : Revoke Avastin Approval As Breast Cancer Treatment ... Send by Damian Dozol A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer. | News-Insurances.com is an independent online [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Cancer Drug Boost To Roche Posted by Hellen Popovich New test results for lung cancer drug Avastin - made by Swiss drug maker Roche - have uncovered no new safety issues with the latest data once again endorsing its use against the disease. [...] Rating: No stars. Rate up / Rate down Report to moderator

July 21, 2010 Experts: Revoke Avastin Approval As Breast Cancer Treatment Send by news.yahoo.com A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer. [...] Rating: 4 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Avastin Risks Outweighed Benefits In 1 Study: FDA Send by www.cbc.ca A follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients, a U.S. Food and Drug Administration panel of experts reviewing the drug has unanimously concluded. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 FDA Questions Effectiveness Of Breast Cancer Drug Avastin Posted by Hellen Popovich The Food and Drug Administration (FDA) approved the cancer drug, Avastin, to treat breast cancer in 2008. It was ?accelerated approved? on condition of more studies being made. [...] Rating: 2 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 Avastin Information From Drugs.com Posted by Hellen Popovich Avastin (bevacizumab) is used to brain tumors and cancers of the kidney, colon, rectum, lung or breast. Includes Avastin side effects, interactions and indications. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

July 20, 2010 FDA Panel: Data Did Not Show Benefits With Avastin Posted by Hellen Popovich Federal health advisers say unanimously that a follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients. from Channel 7 [...] Rating: No stars. Rate up / Rate down Report to moderator

July 21, 2010 Press Navigator Avastin Send by andrew gerrard Welcome guest, You can't predict when knowing something extra about avastin will come in handy. If you learned anything new about avastin in this site, you should start bookmarking this site or post using ctrl+d. [...] Rating: 5 out of 5 stars Rate up / Rate down Report to moderator

---

Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.